Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshitaka Koshino is active.

Publication


Featured researches published by Yoshitaka Koshino.


Nephron | 1986

Gouty Kidney Associated with Membranous Nephropathy: Participation of Renal Tubular Epithelial Antigen

Hitoshi Yokoyama; Hiroshi Kida; Teruo Asamato; Toshio Abe; Yoshitaka Koshino; Nobu Hattori

Histological studies were performed on 3 patients with gout and proteinuria measured at 1.0 g a day or more. Light microscopy revealed diffuse thickening of the glomerular capillary walls accompanied by spike formation and bubble-like appearance as well as tophaceous granuloma in the interstitium, tubular atrophy and benign nephrosclerosis. Immunofluorescence technique showed fine granular deposits of IgG and C3 along the glomerular capillary walls together with the renal tubular epithelial antigen (RTE) in 1 patient. Subepithelial dense deposits were also observed by electron microscopy. These findings suggest that the association of membranous nephropathy should be considered in patients with gout having moderate to severe proteinuria and that RTE may be involved in the pathogenesis of subepithelial deposits in gouty membranous nephropathy.


Therapeutic Apheresis and Dialysis | 2018

Occult Hepatitis B Virus Infection With Increased Virus DNA Levels in a Chronic Hemodialysis Patient: Occult HBV Infection in a Hemodialysis Patient

Yoshitaka Koshino; Yasuyuki Shinozaki; Takashi Wada

Dear Editor, Controlling hepatitis B virus (HBV) infection is a serious issue in dialysis hospitals. Occult HBV infection (OBI) is defined as the presence of HBV genome in the serum or liver tissue without detectable hepatitis B surface antigen (HBsAg). A previous study reported OBI prevalence in Japanese chronic hemodialysis (HD) patients to be 0.3% (1). The patients in that study tested negative for anti‐ hepatitis B surface antibody (HBsAb) and positive for anti‐hepatitis B core antibody (anti‐HBc), and HBV DNA was detected in their sera with a quantitative sensitivity of 2.1 log copies/mL (20 IU/mL). Herein, we report an OBI patient with increased serum HBV DNA levels who was undergoing HD.


Kidney International | 1988

Mesangiolysis in diabetic glomeruli: Its role in the formation of nodular lesions

Yafumi Saito; Hiroshi Kida; Shin-chi Takeda; Mitsuhiro Yoshimura; Hitoshi Yokoyama; Yoshitaka Koshino; Nobu Hattori


Japanese Journal of Medicine | 1982

Vitamin D Resistant Hypophosphatemic Osteomalacia Associated with Osteosarcoma of the Mandible:Report of a Case

Gakuji Nomura; Yoshitaka Koshino; Hideo Morimoto; Hiroshi Kida; Susumu Nomura; Kenzo Tamai


Internal Medicine | 2007

Effect of Sevelamer Hydrochloride on Markers of Bone Turnover in Japanese Dialysis Patients with Low Biointact PTH Levels

Yasunori Iwata; Takashi Wada; Hitoshi Yokoyama; Tadashi Toyama; Shinji Kitajima; Toshiya Okumura; Akinori Hara; Junya Yamahana; Izaya Nakaya; Motoo Kobayashi; Kiyoki Kitagawa; Satoshi Kokubo; Keiichi Yoshimoto; Kazuaki Shimizu; Norihiko Sakai; Kengo Furuichi; Yoshitaka Koshino; Shin-ichi Takeda; Kazuya Takasawa; Satoshi Ohta; Masayoshi Takaeda; Chikako Takaeda; Shuichi Kaneko


Clinical and Experimental Nephrology | 2013

Japan Diabetic Nephropathy Cohort Study: study design, methods, and implementation

Kengo Furuichi; Miho Shimizu; Tadashi Toyama; Daisuke Koya; Yoshitaka Koshino; Hideharu Abe; Kiyoshi Mori; Hiroaki Satoh; Masahito Imanishi; Masayuki Iwano; Hiroyuki Yamauchi; Eiji Kusano; Shouichi Fujimoto; Yoshiki Suzuki; Seiya Okuda; Kiyoki Kitagawa; Yasunori Iwata; Shuichi Kaneko; Shinichi Nishi; Hitoshi Yokoyama; Yoshihiko Ueda; Masakazu Haneda; Hirofumi Makino; Takashi Wada


Japanese Journal of Medicine | 1989

A Case of Diffuse Panbronchiolitis(DPB) with Benign Monoclonal IgA Gammopathy and IgA Nephropathy with Monoclonal IgA Deposition

Takero Naito; Hiroshi Kida; Hitoshi Yokoyama; Yoshitaka Koshino; Naohisa Tomosugi; Nobu Hattori; Kunihiko Kobayashi


Clinical and Experimental Nephrology | 2018

Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS

Miho Shimizu; Kengo Furuichi; Tadashi Toyama; Tomoaki Funamoto; Shinji Kitajima; Akinori Hara; Daisuke Ogawa; Daisuke Koya; Kenzo Ikeda; Yoshitaka Koshino; Yukie Kurokawa; Hideharu Abe; Kiyoshi Mori; Masaaki Nakayama; Yoshio Konishi; Ken-ichi Samejima; Masaru Matsui; Hiroyuki Yamauchi; Tomohito Gohda; Kei Fukami; Daisuke Nagata; Hidenori Yamazaki; Yukio Yuzawa; Yoshiki Suzuki; Shouichi Fujimoto; Shoichi Maruyama; Sawako Kato; Takero Naito; Kenichi Yoshimura; Hitoshi Yokoyama


Nihon Toseki Igakkai Zasshi | 2014

The switch from insulin to vildagliptin in hemodialysis patients with diabetes

Yukie Kurokawa; Yasunori Iwata; Ken-ichiro Kato; Shinji Kitajima; Toshinari Takamura; Takashi Wada; Yoshitaka Koshino


Nihon Toseki Igakkai Zasshi | 2004

Effective therapeutic strategies of oral vitamin D3 and intravenous maxacalcitol on secondary hyperparathyroidism in chronic hemodialysis patients: a prospective trial

Miho Shimizu; Hitoshi Yokoyama; Kengo Furuichi; Motoo Kobayashi; Keiichi Yoshimoto; Yasunori Iwata; Kazuaki Shimizu; Norihiko Sakai; Takashi Wada; Hiroshi Takakuwa; Toshio Abe; Yoshitaka Koshino; Masatomo Maekawa; Masahiko Fujioka; Yasuyuki Ushiogi; Kazuya Takasawa; Chikako Takaeda; Shin'ichi Takeda; Masayoshi Takaeda; Naoteru Hashimoto; Satoshi Ohta; Yoichi Ishida

Collaboration


Dive into the Yoshitaka Koshino's collaboration.

Top Co-Authors

Avatar

Hitoshi Yokoyama

Kanazawa Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge